NHS National Framework for Transition Products (Nintedanib and Dalbavancin)
Estimated value
—
Awarded value
£14.8m
Awarded 25 Feb 2026
Suppliers
7
3 SME
Lots
1
1 awarded
Published
25 Feb 2026
Awarded suppliers· 7 suppliers
Awarded 25 Feb 2026 · Contract period 30 Apr 2026 — 30 Sept 2027
Award value
£14.8m